OSN New York Meeting
OSN New York Meeting
November 24, 2019
2 min watch
Save

VIDEO: Ocular Therapeutix delivers update on Dextenza launch

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

NEW YORK — At the OSN New York 2019 meeting, Scott Corning, senior vice president of commercial, gives an update on the launch of Dextenza, the dexamethasone-eluting intracanalicular insert indicated for the management of inflammation and pain following ophthalmic surgery.